Welcome to Week Oral Delivery II. Starting week four video. Multiple oral doses video. Calculating Cp for an oral drug
|
|
- Avis Allison
- 6 years ago
- Views:
Transcription
1 Welcome to Week 4 Starting week four video Please watch the online video (46 seconds). 7.7 Oral Delivery II Multiple oral doses video Please watch the online video (7 minutes, 34 seconds). A condensed summary of this video can be found in the Video summary page. Calculating Cp for an oral drug Background: The C p of an oral drug is equal to the sum of the remaining drug from all the previous doses administered to a patient. Instructions: Read the passage below on calculating C p for a drug and use the information to answer the assessment questions that follow. Learning Goals: To understand better how to determine C p values for oral drugs at different time points. The C p for an oral drug dose can be calculated at any time with the formula below if all the variables are known.
2 Any reference with pharmacokinetic parameters on drugs will list bioavailabilty (F), volume of distribution (V d ), half life (t 1/2 ), and t max, among others. k el can be calculated from t 1/2. k ab can be estimated from t max and k el (with some trial and error). With these parameters in hand, one can calculate C p at any time. In order to determine C p from many doses, one must calculate the C p from each dose and add them together. An important idea to remember is that the time of each dose is different. For example, if a drug is dosed every 4 hours, then at 10 hours, C p dose 1 would be calculated at the full time of 10 hours, but C p dose 2 would be calculated at only 6 hours, and C p dose 3 would be calculated at just 2 hours. Please complete the online exercise. Complexities of dosing Background: A successful dosing regimen usually involves administering a drug so that the concentration of the drug remains within a window that provides a therapeutic effect without demonstrating toxic effects. Instructions: Read the case study on daptomycin, a drug that poses particularly difficult dosing challenges. Learning Goal: To gain exposure to more subtle issues surrounding the dosing of drugs. Daptomycin is a large antibiotic. Daptomycin violates Lipinski's rules in just about every way possible. Its molecular weight is 1,620 g/mol, well above the 500 g/mol limit of Lipinski. Daptomycin also has far more than 5 hydrogen bond donors and 10 hydrogen bond acceptors. Based on these traits, one might expect that daptomycin has a very low oral bioavailability. That expectation is correct. Daptomycin cannot be formulated as an oral drug and is instead administered intravenously. (See structure on following page.)
3 The antibacterial activity of daptomycin was originally discovered by scientists at Eli Lilly in the 1980s. The therapeutic effect of daptomycin is accompanied with toxicity to muscle tissues. Unfortunately, the concentrations required for the antibacterial activity of daptomycin are very similar to those that cause muscle toxicity. Researchers at Eli Lilly explored several options for administering daptomycin and ultimately focused upon a twice daily IV regimen. The hope was that a twice daily dosing would provide a narrower range for C p in the patient. By hitting a narrow C p range, the drug may be able to hit concentrations ideal for antibacterial activity and yet avoid or minimize the toxic effects. A representation of C p vs. time for both once daily (black line) and twice daily (red line) dosing is shown below. Note that the twice daily schedule does keep C p of daptomycin within a tighter range.
4 Unfortunately, researchers at Eli Lilly were unable to separate satisfactorily the antibacterial and toxic effects of daptomycin. Eli Lilly closed their daptomycin research program. Another company, Cubist, expressed interest in reviving the project. Eli Lilly then entered an agreement with Cubist, and Cubist started its own research program in daptomycin in This type of arrangement is common between drug companies. Large companies often have more potential projects than available resources. Projects that are not making progress will be shelved to free resources for more promising ones. Partnering with another company allows more projects to be in development. If the shared project is successful, then both companies will share in the profits. The drug discovery group at Cubist pursued a once daily dosing regimen for daptomycin. Instead of minimizing the peak C p values of daptomycin with twice daily dosing, Cubist's approach emphasized the deeper C p troughs of a once daily dosing. Cubist found that the muscle toxicity effects could be minimized without sacrificing antibacterial activity. One possible interpretation is that the deeper dips in C p in the once daily regimen allow the muscles to recover periodically from the toxic effects of the drug. Cubist obtained a patent on their specific and novel dosing schedule which was counter to the prevailing logic on daptomycin. Even though the composition of matter patent on daptomycin has expired, generic manufacturers have been excluded from the market because of Cubist's dosing patent. The case of daptomycin demonstrates how each drug brings its unique challenges to drug discovery. The therapeutic and toxic levels of each drug create new issues that must be addressed by medicinal chemists. 7.8 CL and Vd Revisited CL vs. Vd plots video Please watch the online video (7 minutes, 27 seconds). A condensed summary of this video can be found in the Video summary page.
5 Modifying structures to improve PK Background: A CL vs. V d plot is an excellent tool for providing insight into how a drug's structure might be modified in order to optimize its pharmacokinetics. Instructions: Answer the questions below. Learning Goal: To learn how to modify a drug or lead in order to achieve desired pharmacokinetic properties. Daptomycin is a large antibiotic. Daptomycin violates Lipinski's rules in just about every way possible. Its molecular weight is 1,620 g/mol, well above the 500 g/mol limit of Lipinski. Daptomycin also has far more than 5 hydrogen bond donors and 10 hydrogen bond acceptors. Based on these traits, one might expect that daptomycin has a very low oral bioavailability. That expectation is correct. Daptomycin cannot be formulated as an oral drug and is instead administered intravenously. (See structure on following page.) Please complete the online exercise. Chapter 8 Metabolism Introduction to Chapter 8 Chapter 8 contains six subsections. Introduction Phase I Pt 1 Phase I Pt 2 Phase II Metabolite Issues Prodrugs
6 Upon completing this chapter, you should understand the common types of drug metabolism reactions that occur in the body and how to recognize and predict those reactions. You should also recognize the complications that metabolites introduce to drug discovery based on demographic difference and biological activity of the metabolites. Finally, you will see drug metabolism as an exploitable process to improve the bioavailability of certain drugs. 8.1 Introduction Metabolism and Vd video Please watch the online video (7 minutes, 9 seconds). A condensed summary of this video can be found in the Video summary page. Comparing metabolites Background: When drugs are metabolized, the resulting metabolites are typically (but not always) more polar than the original drug. One simple method for comparing the polarity of two compounds is through lipophilicity, log P. In general, compounds with a lower lipophilicity (lower log P), have a lower V d and a shorter half life. Instructions: Use data from the DrugBank ( answer the questions below. Learning Goal: To understand more fully how metabolism can affect a drug and its metabolites in terms of polarity and V d. Please complete the online exercise. 8.2 Phase I Pt I Oxidation video Please watch the online video (6 minutes, 52 seconds). A condensed summary of this video can be found in the Video summary page.
7 Omega oxidation Background: Most oxidations of sp 3 hybridized carbons occur adjacent to a nitrogen or oxygen atom and cause dealkylation of the nitrogen or oxygen. Instructions: Read the passage below for an example of another type of sp 3 hybridized carbon oxidation. Learning Goal: To see another somewhat common type of Phase I oxidation. Oxidations of simple sp 3 hybridized carbon atoms are less rapid because the oxidation is not activated by an adjacent oxygen or nitrogen atom. Simple alkyl chains can regardless undergo metabolism in the body. These oxidations are called ω oxidations (omega oxidations). One classic example of an ω oxidation was seen in the previous subsection. Terfenadine, an antihistamine, undergoes ω oxidation on one of the tert butyl carbons. The C H bond is presumably oxidized to an alcohol, which is rapidly oxidized to an aldehyde and then the acid. Interestingly, the acid metabolite is itself also an antihistamine drug.
8 Another example of an ω oxidation can be found in the antidiabetic chlorpropamide. The propyl chain in chlorpropamide actually undergoes two different ω oxidations. One is on the end of the propyl chain. This is a true ω oxidation as it occurs on the end (omega) of the chain. The other is an oxidation on the second to last carbon. This is formally called an ω 1 oxidation because it occurs one carbon removed from the end of the chain. While ω oxidations are less common than other types of Phase I metabolic reactions, they are encountered with some regularity. Predicting phase I metabolites Background: Based on the functional groups in a molecule, the most likely metabolites of a drug can often be predicted. Instructions: In the questions below, predict likely structures of metabolites of mepyramine, one of the early antihistamine drugs. Drawing the metabolite structures will require you to watch a video on the use of JSDraw, a chemistry drawing program. Learning Goals: To learn how to use JSDraw and gain experience predicting metabolites. JSDraw tutorial video Please watch the online video (4 minutes, 33 seconds). Please complete the online exercise.
9 8.3 Phase I Pt II Reduction and hydrolysis video Please watch the online video (3 minutes, 55 seconds). A condensed summary of this video can be found in the Video summary page. Predicting phase I metabolites Background: One can often predict the metabolites of a drug based on the drug's functional groups. Instructions: In the questions below, predict likely phase I structures of metabolites of the indicated drugs. Learning Goal: To gain experience predicting phase I metabolites of a drug. Please complete the online exercise. 8.4 Phase II Conjugation video Please watch the online video (6 minutes, 41 seconds). A condensed summary of this video can be found in the Video summary page. Role of glutathione Background: Glutathione is a nucleophilic molecule that reactions with electrophilic molecules in the liver. Instructions: Read the passage below concerning how glutathione protects the liver and body from being damaged by certain drugs. Learning Goals: To understand better how the liver metabolizes drugs and the limits of the liver in detoxification. The liver breaks down drugs, primarily through its arsenal of oxidative CYP 450 enzymes. The process of oxidation involves the loss of electrons. As a molecule loses electrons, it becomes electron poor and therefore more electrophilic. Strong electrophiles, which are often formed
10 through metabolic reactions, can be very damaging to cells. This raises a question... How can the liver continuously perform oxidative reactions on drugs and other molecules without being extensively damaged by electrophilic metabolites? The answer is that the liver is protected by processes such as glutathione conjugation. Glutathione, a natural nucleophile through its thiol group, reacts with strong electrophiles and sacrifices itself before the liver tissue is damaged. The protection of the liver is only limited by the liver's stores of glutathione. The concentration of glutathione in the liver is around 5 mm. If a person ingests too much of a compound that reacts with glutathione, then once the glutathione reserves are consumed, the liver will be damaged. It is for this reason that drug overdoses often lead to extensive liver damage Predicting phase II metabolites Background: Based on the functional groups in a molecule, the metabolites of a drug can often be predicted. Instructions: In the questions below, predict likely structures of phase II metabolites of the drugs that are shown. Learning Goal: To gain experience predicting phase II metabolites. Please complete the online exercise. 8.5 Metabolism Issues Metabolism inhibition video Please watch the online video (7 minutes, 24 seconds). A condensed summary of this video can be found in the Video summary page.
11 Case study cimetidine Background: Drugs that inhibit any of the CYP enzymes have the potential to interfere with the metabolism of other drugs. This type of drug interaction can cause safety problems and affect the marketability of a drug. Instructions: Read the passage below about CYP inhibition of cimetidine. Learning Goals: To learn about the implications of CYP inhibition of a drug. Cimetidine is a histamine H 2 receptor antagonist and represented a first in class drug for the treatment of acid reflux. Cimetidine was marketed in the United States in 1979 under the brand name Tagamet. Cimetidine met great success and enjoyed high sales. In 1983 another histamine H 2 receptor antagonist, ranitidine, reached the market in the United States. Ranitidine, sold under the name of Zantac, has a structure that is strikingly similar to cimeditine. Ranitidine is an example of a me too drug. Me too drugs tend to follow quickly behind a first in class drug and have similar structures. The composition of matter patents surrounding cimetidine emphasized the importance of the imidazole ring for the activity of histamine H2 receptor antagonists. The researchers who discovered ranitidine were able to use a furan ring in place of imidazole and still maintain activity. A me too drug rarely matches the profitability of the first drug in a class. The first drug dominates the market, and the me too drug lags behind. Ranitidine, however, surpassed the market share of cimetidine in a just a few years. The reason behind the success of ranitidine was CYP inhibition by cimetidine. Cimetidine inhibits several forms of CYP, including CYP1A2, CYP2D6, and, most importantly, CYP3A4. Cimetidine therefore has a long list of drug interactions. While ranitidine also inhibits several CYP forms, ranitidine is a less potent inhibitor than cimetidine. Many patients who experienced complications with cimetidine switched to ranitidine
12 Factors in metabolism Background: Based on the functional groups in a molecule, the metabolites of a drug can often be predicted. Instructions: Genetic differences can play a significant role in how a drug is metabolized in one patient or another. Other factors also are important. Learning Goal: To learn how health and age affect drug metabolism. While genetic differences can affect drug metabolism, metabolic differences between people of different races are typically very small, even negligible. Gender is yet another factor that is normally of little importance when discussing metabolism. Other factors, including age and health, are far more influential with regard to drug metabolism. The compound theophylline, a drug sometimes used to treat asthma, highlights these differences. 1 Age can greatly influence drug metabolism. Below is a table showing how half life can vary with age for theophylline. Bear in mind that theophylline is cleared primarily by the liver, so changes in halflife reflect changes in liver activity. age half life (h) infants (1 2 days) 25.7 infants (3 30 weeks) 11.0 children (1 4 years) 3.4 children (6 17 years) 3.7 adults (18 60 years) 8.7 elderly (>60 years) 9.8
13 The variability of the half life of theophylline shows how metabolism changes with age. Very young infants are not completely developed metabolically, so the half life is long. By an age of 12 months, children are metabolically extremely active and the half life of theophylline drops below 4 hours. Once a person matures physically, the half life lengthens to just under 9 hours. Late in life, as a person's metabolism gradually slows, the half life of theophylline also lengthens slightly. Physical health can also affect the half life of a drug. Below is a table showing how half life can vary with health or physical condition for theophylline. condition half life (h) liver cirrhosis 32.0 hepatitis 19.2 pregnancy (1st trimester) 8.5 pregnancy (2nd trimester) 8.8 pregnancy (3rd trimester) 13.0 sepsis 18.8 hypothyroid 11.6 hyperthyroid 4.5 Conditions that negatively affect or place stress on the liver (cirrhosis, hepatitis, late pregnancy, blood infection, and hypothyroid) lengthen the half life of theophylline. Hyperthyroidism, a condition in which a patient has an accelerated metabolism (among other things), causes a dramatic decrease in half life. Another condition that frequently affects a drug's half life is diabetes. Advanced diabetic patients often have limited kidney function. Renal clearance is diminished, and drugs that rely on the kidneys for clearance have lengthened half lives. 1. Murray, L., Sr. (Ed.). Physician's Desk Reference (58th ed.) Montvale, NJ: Thomson PDR, 2004.
14 Pharmacokinetic scatter Background: Drugs are listed with distinct pharmacokinetic parameters. These parameters provide a sense of precision for a drug and exactly how it behaves. Instructions: Read the short passage below and review the figures in the linked article ( in Antimicrobial Agents and Chemotherapy and answer the questions that follow. Learning Goal: To appreciate the broad variability in the action of drugs across different patients. One of the drugs used to prevent and treat malaria is mefloquine. Mefloquine is administered orally in its racemic form and is well absorbed. The drug is mostly excreted through the bile, meaning it is absorbed, collected in the gall bladder, excreted in bile, and exits the body in feces. Compounds found in the feces are often not absorbed, but in this case, the drug is indeed absorbed from the gastrointestinal tract. In a study on mefloquine dosing, 50 patients received 8 mg mefloquine per kg of body mass (8 mg/kg) on Day 0, Day 1, and Day 2 of the study. Patients were then monitored for approximately one month for their C p levels of mefloquine. From this data, the pharmacokinetic parameters of mefloquine could be determined. The ideal C p time curve ( shows a smooth, predictable relationship between C p and time. The scatter plot ( of the experimental data gives a much less convincing relationship based on a visual inspection. The scatter seen in the experimental graph is representative of experimental pharmacokinetic data. The behavior of a drug can vary wildly among different patients. It is for this reason, in part, that drug must have a wide therapeutic window. Please complete the online exercise.
15 8.6 Prodrugs Prodrugs video Please watch the online video (6 minutes, 43 seconds). A condensed summary of this video can be found in the Video summary page. Case study antiplatelet drugs Background: Prodrugs are compounds that are converted in the body to the biologically active form of the molecule. Many prodrugs are administered in an inactive form because the active form is not well absorbed. Instructions: Read the passage below about two antiplatelet drugs, clopidogrel and prosugrel. Learning Goal: To understand that metabolic activation of a prodrug can have problematic genetic variability across a broad patient population. Antiplatelet drugs are compounds that inhibit clot formation and therefore reduce the incidence of stroke, heart attacks, and other clot dependent conditions. Antiplatelet drugs can fall into several different classes, one of which is the adenosine diphosphate receptor inhibitors. Two examples of adenosine diphosphate receptor inhibitors are clopidogrel and prasugrel. Both clopidogrel and prasugrel are prodrugs. Clopidogrel was approved by the US FDA in The compound is activated in the body by phase I oxidation of the thiophene ring. One of the sp 2 hybridized carbons in the ring is oxidized by CYP2C19. The resulting hydroxythiophene is unstable and hydrolyzes to give the ring opened, active form of the drug.
16 Around 5 10% of the US population have a genetic variation in CYP2C19 that renders the enzyme less active in the metabolism of clopidogrel. For these patients clopidogrel is not activated properly in the body, and the patients do not have therapeutically effective levels of the metabolite. Because of the potential lack of effect of prosugrel, the FDA added labeling in 2010 to clopidogrel packing to indicate the possible lack of effectiveness of the drug. This so called black box warning raises safety awareness and concerns for both prescribing physicians and patients. Prasugrel is in the same drug class as clopidogrel and was approved in Prasugrel is nearly identical in structure to clopidogrel. The major difference is that the thiophene ring already bears an oxygen. The ring is essentially oxidized in its administered form. In the body the drug is activated by hydrolysis of the acetate ester to form the hydroxythiophene metabolite, which forms the active form of the drug. Prasugrel, which is activated by plasma lipases instead of CYP2C19, shows fewer variations in how it is metabolized across broad populations of patients. For this reason, prasugrel is not packaged with black box warnings. Prasugrel is an example of how understanding metabolic issues of a drug allowed the clever design of a safer version of what is otherwise a nearly identical drug. Drawing prodrugs Background: Prodrugs are compounds that are converted in the body to the biologically active form of the molecule. Instructions: Do the problems below by predicting the structure of the prodrug based on the structure of its active metabolite. Learning Goal: To recognize how particular functional groups can be formed in the body through metabolic reactions. Please complete the online exercise.
17 Survey Week 4 Survey Please complete the very brief online survey, which should take less than one minute. Examination 2 Second Examination The exam is open book and open notes. All questions may be attempted once, so be certain of your answer before submitting it. There are ten questions. Each is its own unit within the Examination 2 subsection. Remember that you are bound by the honor code. No postings to the forum concerning the exam are allowed. Furthermore, you must work on the examination independently Problems Please complete the online problems in Examination 2.
Chapter 4. Drug Biotransformation
Chapter 4 Drug Biotransformation Drug Biotransformation 1 Why is drug biotransformation necessary 2 The role of biotransformation in drug disposition 3 Where do drug biotransformation occur 4 The enzymes
More informationBasic Concepts of TDM
TDM Lecture 1 5 th stage What is TDM? Basic Concepts of TDM Therapeutic drug monitoring (TDM) is a branch of clinical pharmacology that specializes in the measurement of medication concentrations in blood.
More informationDEPARTMENT OF PHARMACOLOGY AND THERAPEUTIC UNIVERSITAS SUMATERA UTARA
METABOLISME dr. Yunita Sari Pane DEPARTMENT OF PHARMACOLOGY AND THERAPEUTIC UNIVERSITAS SUMATERA UTARA Pharmacokinetic absorption distribution BIOTRANSFORMATION elimination Intravenous Administration Oral
More informationMedicinal Chemistry I Examination Name December 15, 2009 Med. Chem. #
Medicinal Chemistry Examination ame December 15, 2009 Med. Chem. # Part. 80 Points (40 Questions; 2 Points Each) Select the BEST answer for each of the following. f none of the answers are correct, do
More informationPHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.
PHA 5127 Final Exam Fall 2012 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Please transfer the answers onto the bubble sheet. The question number refers
More information1. If the MTC is 100 ng/ml and the MEC is 0.12 ng/ml, which of the following dosing regimen(s) are in the therapeutic window?
Page 1 PHAR 750: Biopharmaceutics/Pharmacokinetics October 23, 2009 - Form 1 Name: Total 100 points Please choose the BEST answer of those provided. For numerical answers, choose none of the above if your
More informationPHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.
PHA 5127 Second Exam Fall 2012 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Put all answers on the bubble sheet TOTAL /150 pts 1 Question Set I (True or
More informationIbuprofen. Ibuprofen and Paracetamol: prescribing overview. Ibuprofen indications CYCLO-OXYGENASE (COX I) CYCLO-OXEGENASE (COX II) INFLAMMATORY PAIN
Ibuprofen Ibuprofen and Paracetamol: prescribing overview Sarah Holloway Macmillan CNS in palliative care NSAID Non-selective COX inhibitor Oral bioavailability: 90% Onset of action: 20-30 mins (can take
More informationBasic Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics
Basic Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics Learning Outcomes Define biopharmaceutics Describe 4 processes of pharmacokinetics Describe factors that affect medication absorption Describe
More informationPharmacokinetics for Physicians. Assoc Prof. Noel E. Cranswick Clinical Pharmacologist Royal Children s Hospital Melbourne
Pharmacokinetics for Physicians Assoc Prof. Noel E. Cranswick Clinical Pharmacologist Royal Children s Hospital Melbourne The Important Therapeutic Questions What drug? What dose? How long? Drug Dosage
More informationChapter 5. The Actions of Drugs. Origins of Drugs. Names of Drugs. Most drugs come from plants or are chemically derived from plants
Chapter 5 The Actions of Drugs Origins of Drugs Most drugs come from plants or are chemically derived from plants Names of Drugs Chemical name: Complete chemical description of the molecule Example: N'-[2-[[5-(dimethylaminomethyl)-2-furyl]
More informationThe ADME properties of most drugs strongly depends on the ability of the drug to pass through membranes via simple diffusion.
1 MEDCHEM 562 Kent Kunze Lecture 1 Physicochemical Properties and Drug Disposition The ADME properties of most drugs strongly depends on the ability of the drug to pass through membranes via simple diffusion.
More informationSection 5.2: Pharmacokinetic properties
Section 5.2: Pharmacokinetic properties SmPC training presentation Note: for full information refer to the European Commission s Guideline on summary of product characteristics (SmPC) SmPC Advisory Group
More informationTofacitinib ( Xeljanz) Marshall Porter & Lauren Ysais
Tofacitinib ( Xeljanz) Marshall Porter & Lauren Ysais Learning Objectives to Take with You A small molecule Janus Kinase (JAK) Inhibitor treatment for moderate to severe rheumatoid arthritis (RA) reduces
More informationIndustrial Toxicology
Industrial Toxicology Learning Objectives Know the assumptions of the doseresponse and time-course curves Be able to define and label key points of a curve Know the difference between potency and efficacy
More informationIntroduction to Pharmacokinetics (PK) Anson K. Abraham, Ph.D. Associate Principal Scientist, PPDM- QP2 Merck & Co. Inc., West Point, PA 5- June- 2017
Introduction to Pharmacokinetics (PK) Anson K. Abraham, Ph.D. Associate Principal Scientist, PPDM- QP2 Merck & Co. Inc., West Point, PA 5- June- 2017 1 Outline Definition & Relevance of Pharmacokinetics
More informationPHA 5127 FINAL EXAM FALL On my honor, I have neither given nor received unauthorized aid in doing this assignment.
PHA 5127 FINAL EXAM FALL 1997 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question Points 1. /14 pts 2. /10 pts 3. /8 pts 4 /8 pts 5. /12 pts 6. /8 pts
More informationIntroducing Pharmacokinetics and Pharmacodynamics. Janice Davies Pharmacist Room 23 Maudland Building
Introducing Pharmacokinetics and Pharmacodynamics Janice Davies Pharmacist Room 23 Maudland Building JADavies5@uclan.ac.uk 1 elearn 2 DVD Any problems / questions? 3 Learning outcomes Define and discuss
More informationPHA5128 Dose Optimization II Case Study I Spring 2013
Silsamicin is an investigational compound being evaluated for its antimicrobial effect. The route of administration for this drug is via intravenous bolus. Approximately 99.9% of this drug is eliminated
More informationADRENERGIC RECEPTOR ANTAGONISTS: ALPHA RECEPTOR BLOCKERS
Jack Deuiter, Principles of Drug Action 2, Fall 2000 ADEEGIC ECEPT ATAGISTS: ALPA ECEPT BLCKES General PC/MC: Understand the term "antagonist" and how an antagonist is similar to an agonist, and how an
More informationA condensed summary of this video can be found in the Video summary page.
Welcome to Week 3 Starting week three video Please watch the online video (1 minutes, 6 seconds). Chapter 6 - Blood and Drug Transport Introduction to Chapter 6 Chapter 6 contains two subsections. Blood
More informationLD = (Vd x Cp)/F (Vd x Cp)/F MD = (Css x CL x T)/F DR = (Css x (Vm-DR))/Km Css = (F x D)/(CL x T) (Km x DR)/(Vm DR)
PHARMKIN WORKSHOP A PHARMACOKINETICS TEACHING SIMULATION Joseph K. Ritter, Ph.D. Associate Professor, Pharmacology and Toxicology MSB 536, 828-1022, jritter@mail2.vcu.edu Tompkins-McCaw Libray Room 2-006
More informationIntroduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D
Introduction to 1 Pharmacokinetics University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 2 Learning objectives Understand compartment models and how they effects
More informationPharmacokinetics Applied to the Treatment of Asthma
Pharmacokinetics Applied to the Treatment of Asthma 2016 edition by David C. McMillan, PhD Department of Pharmacology and Experimental Neuroscience College of Medicine University of Nebraska Medical Center
More informationComposition: Each tablet contain. Levocetirizine. Each 5ml contains. Montelukast. Pharmacokinetic properties:
Composition: Each tablet contain Montelukast Levocetirizine 10mg 5mg Each 5ml contains Montelukast Levocetirizine 4mg 2.5mg Pharmacokinetic properties: Peak plasma concentrations of montelukast are achieved
More informationCytochrome P450 Drug Interaction Table Flockhart Table
Cytochrome P450 Drug Interaction Table Flockhart Table The table contains lists of drugs in columns under the designation of specific cytochrome P450 isoforms. CYTOCHROME P450 DRUG INTERACTION TABLE A
More informationPHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.
PHA 5127 Final Exam Fall 2010 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Please transfer the answers onto the bubble sheet. The question number refers
More informationBasic Principles in Pharmacology
L. 1 Dr. Mohammed AL-Zobaidy Basic Principles in Pharmacology Learning objectives: by the end of this lecture you should Understand the possible uses of drugs. Explain why a drug has different names. Identify
More informationClick to edit Master title style
A Short Course in Pharmacokinetics Chris Town Research Pharmacokinetics Outline Pharmacokinetics - Definition Ideal Pharmacokinetic Parameters of a New Drug How do we optimize PK for new compounds Why
More informationDetermination of bioavailability
Pharmaceutics 2 Bioavailability Bioavailability is the rate and extent to which an administered drug reaches the systemic circulation. For example, if 100 mg of a drug is administered orally and 70 mg
More informationMTnL Tablet/ MTnL Kid Tablet Montelukast & Levocetirizine dihydrochloride
MTnL Tablet/ MTnL Kid Tablet Montelukast & Levocetirizine dihydrochloride COMPOSITION MTnL Tablets Each film-coated tablet contains: Montelukast sodium equivalent to montelukast Levocetirizine dihydrochloride
More informationChapter 6, Part Read Activity 6A - Choosing a Meal and orally attempt the procedure and discussion on page 99.
Science 9 Unit 1 Worksheet Chapter 6, Part 1. 1. Read Activity 6A - Choosing a Meal and orally attempt the procedure and discussion on page 99. 2. Your body is made up of,,,, and many other materials.
More informationCLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE
CLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE Joseph K. Ritter, Ph.D. Assoc. Professor, Pharmacology and Toxicology MSB 536, 828-1022, jritter@vcu.edu This self study module will reinforce the
More informationPaper 9: ORGANIC CHEMISTRY-III (Reaction Mechanism-2) Module17: Reduction by Metal hydrides Part-II CHEMISTRY
Subject Chemistry Paper No and Title Module No and Title Module Tag 9: ORGANIC -III (Reaction Mechanism-2) 17: Reduction by Metal hydrides Part-1I CHE_P9_M17 Table of Contents 1. Learning Outcomes 2. Introduction
More informationTamer Barakat. Abdul Aziz ALShamali. Abdul Aziz ALShamali
10 Tamer Barakat Abdul Aziz ALShamali Abdul Aziz ALShamali Dr. Alia Elimination: Refampin is used to treat TB not malaria (Quinacrine is used for malaria) It s the opposite process of absorption. It's
More informationCOMPOSITION. A film coated tablet contains. Active ingredient: irbesartan 75 mg, 150 mg or 300 mg. Rotazar (Film coated tablets) Irbesartan
Rotazar (Film coated tablets) Irbesartan Rotazar 75 mg, 150 mg, 300 mg COMPOSITION A film coated tablet contains Active ingredient: irbesartan 75 mg, 150 mg or 300 mg. Rotazar 75 mg, 150 mg, 300 mg PHARMACOLOGICAL
More informationMEDCHEM 570. First Midterm. January 30, 2015
Name MEDCHEM 570 First Midterm January 30, 2015 Instructions: Exam packet totals 7 pages. The last page has a 5 points extra credit question. If you need additional space for a question go to the back
More informationBrand and Generic Drugs. Educational Objectives. Absorption
Peter J. Rice, PharmD, PhD Associate Professor of Pharmacology East Tennessee State University Educational Objectives Pharmacokinetic Processes Distribution Metabolism Excretion Similarities Active ingredient(s)
More informationPHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.
PHA 5127 Second Exam Fall 2011 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Put all answers on the bubble sheet TOTAL /200 pts 1 Question Set I (True or
More informationTala Saleh. Abdul Aziz ALShamali. Abdul Aziz ALShamali
9 Tala Saleh Abdul Aziz ALShamali Abdul Aziz ALShamali Alia Shatanawi Volume of Distribution (Vd) Understand the concept Imagine having a container with an unknown volume of water in it. Then 1000mg of
More informationUnderstand the physiological determinants of extent and rate of absorption
Absorption and Half-Life Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland, New Zealand Objectives Understand the physiological determinants of extent and rate of absorption
More informationPrelab 6: Carboxylic Acids
The Structure of Carboxylic Acids Prelab 6: Carboxylic Acids Carboxylic acids contain a carboxyl functional group attached to a hydrocarbon (alkyl group) part. Carboxyl groups contain both a carbonyl group,
More informationDrug dosing in Extremes of Weight
Drug dosing in Extremes of Weight The Plump & Heavy versus The Skinny & Light Maria Minerva P. Calimag, MD, MSc, PhD, DPBA, FPSECP PROFESSOR Departments of Pharmacology, Anesthesiology and Clinical Epidemiology
More informationOne-Compartment Open Model: Intravenous Bolus Administration:
One-Compartment Open Model: Intravenous Bolus Administration: Introduction The most common and most desirable route of drug administration is orally by mouth using tablets, capsules, or oral solutions.
More informationThrombosis Research active studies
Thrombosis Research active studies A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients With Coronary Artery Disease Undergoing PCI With CYP2C19 Loss-of-function Genotypes: A Feasibility
More informationCase Study 2 Answers Spring 2006
Case Study 2 Answers Spring 2006 1. The volume of distribution of diazepam in a group of normal subjects (60 kg, ideal body weight) was found to be 105 L. In another group of patients (110 kg), the volume
More informationMETABOLISM. Ali Alhoshani, B.Pharm, Ph.D. Office: 2B 84
METABOLISM Ali Alhoshani, B.Pharm, Ph.D. ahoshani@ksu.edu.sa Office: 2B 84 Metabolism By the end of this lecture, you should: Recognize the importance of biotransformation Know the different sites for
More informationazilsartan medoxomil
azilsartan medoxomil edarbi 40mg Tablet 80mg Tablet ANTIHYPERTENSIVE Angiotensin II Receptor Antagonist FORMULATION: Each tablet contains 40mg Azilsartan medoxomil (as potassium) Each tablet contains 80mg
More informationBassett Healthcare Clinical Laboratory
Therapeutic Drug Level Collection Guidelines Anti-epileptic drugs (carbamazepine, phenobarbital, phenytoin, primidone, valproic acid) Consider collecting after steady state conditions are reached, i.e.
More informationTDM. Measurement techniques used to determine cyclosporine level include:
TDM Lecture 15: Cyclosporine. Cyclosporine is a cyclic polypeptide medication with immunosuppressant effect. It has the ability to block the production of interleukin-2 and other cytokines by T-lymphocytes.
More informationPHARMACEUTICAL INFORMATION AZILSARTAN
AZEARLY Tablets Each Tablet Contains Azilsartan 20/40/80 mg PHARMACEUTICAL INFORMATION AZILSARTAN Generic name: Azilsartan Chemical name: 2-Ethoxy-1-{[2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-4-biphenylyl]methyl}-
More informationMEDCHEM 562. First Midterm (KEY) October 15, 2012
ame MEDCEM 562 irst Midterm (KEY) ctober 15, 2012 Instructions: Exam packet totals 5 pages. If you need additional space go to the back of that page and tell me you did so. Write legibly and in complete
More informationMITOCW watch?v=xms9dyhqhi0
MITOCW watch?v=xms9dyhqhi0 The following content is provided under a Creative Commons license. Your support will help MIT OpenCourseWare continue to offer high-quality, educational resources for free.
More informationPHARMACOKINETICS SMALL GROUP II:
PHARMACOKINETICS SMALL GROUP II: Question 1 Why are some drug therapies initiated with a loading dose? Emphasize that LD establishes initial therapeutic level quickly. The time to reach the steady-state
More informationChapter 10. Carboxylic Acids and Derivatives. Naming Carboxylic Acids and Derivatives. Carboxylic Acids: RCOOH (RCO 2 H)
Chapter 10 Carboxylic Acids and Derivatives Naming Carboxylic Acids and Derivatives Carboxylic Acids: RCH (RC 2 H) The functional group of a carboxylic acid is a carboxyl group (carbonyl & hydroxyl group)
More informationMEDCHEM 562. Physicochemical Properties of Drugs: Lecture 2; Kent Kunze. Stereochemistry (Double the trouble. or double the fun?)
1 MEDCHEM 562 Physicochemical Properties of Drugs: Lecture 2; Kent Kunze Stereochemistry (Double the trouble. or double the fun?) The vast majority of drugs contain at least one stereo-center or site of
More informationDrug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila
Drug Dosing in Renal Insufficiency Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila Declaration of Conflict of Interest For today s lecture on Drug Dosing in Renal
More informationPharmacokinetics in the critically ill. Intensive Care Training Program Radboud University Medical Centre Nijmegen
Pharmacokinetics in the critically ill Intensive Care Training Program Radboud University Medical Centre Nijmegen In general... Critically ill patients are at higher risk for ADE s and more severe ADE
More informationDrugs, Society and Behavior
SOCI 270 Drugs, Society and Behavior Professor Kurt Reymers, Ph.D. Chapter 5 The Actions of Drugs 2011 McGraw-Hill Higher Education. All rights reserved. 1. Drug Facts a. Sources: Most drugs come from
More informationToxicant Disposition and Metabolism. Jan Chambers Center for Environmental Health Sciences College of Veterinary Medicine
Toxicant Disposition and Metabolism Jan Chambers Center for Environmental Health Sciences College of Veterinary Medicine chambers@cvm.msstate.edu Definitions Disposition Absorption passage across membrane.
More informationTake-Home Exam Distributed: October 19, 2012, at 2:30 p.m. Due: October 24, 2012, at 1:30 p.m.
20.201 Take-Home Exam Distributed: October 19, 2012, at 2:30 p.m. Due: October 24, 2012, at 1:30 p.m. Directions: This take-home exam is to be completed without help from any other individual except Drs.
More informationLevocetirizine dihydrochloride
INSERT TEXT UAP Levocetirizine dihydrochloride Allerzet 5 mg Tablet Antihistamine FORMULATION Each film-coated tablet contains: Levocetirizine dihydrochloride.. 5 mg PRODUCT DESCRIPTION Levocetirine 5
More informationIt the process by which a drug reversibly leaves blood and enter interstitium (extracellular fluid) and/ or cells of tissues.
It the process by which a drug reversibly leaves blood and enter interstitium (extracellular fluid) and/ or cells of tissues. Primarily depends on: 1.Regional blood flow. 2.Capillary permeability. 3.Protein
More informationB. Incorrect! Compounds are made more polar, to increase their excretion.
Pharmacology - Problem Drill 04: Biotransformation Question No. 1 of 10 Instructions: (1) Read the problem and answer choices carefully, (2) Work the problems on paper as 1. What is biotransformation?
More informationChapter 20: Carboxylic Acids and Nitriles شیمی آلی 2
Chapter 20: Carboxylic Acids and Nitriles شیمی آلی 2 Dr M. Mehrdad University of Guilan, Department of Chemistry, Rasht, Iran m-mehrdad@guilan.ac.ir Based on McMurry s Organic Chemistry, 7 th edition The
More informationCLINICAL INVESTIGATION OF MEDICINAL PRODUCTS IN GERIATRICS *)
3CC9a CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS IN GERIATRICS *) Guideline Title Clinical Investigation of Medicinal Products in Geriatrics*) Legislative basis Directive 75/318/EEC, as amended Date
More informationLACIPIL QUALITATIVE AND QUANTITATIVE COMPOSITION
LACIPIL lacidipine QUALITATIVE AND QUANTITATIVE COMPOSITION Lacidipine, 2 mg - round shaped white engraved on one face. Lacidipine, 4 mg - oval white with break line on both faces. Lacidipine, 6 mg - oval
More informationIdentifying Functional Groups. (Chapter 2 in the Klein text)
Identifying Functional Groups (Chapter 2 in the Klein text) Basic Ideas A functional group is a substructure within a molecule that will have the potential to undergo chemical change, i.e. the group has
More informationPharmacokinetic parameters: Halflife
Pharmacokinetic parameters: Halflife (t 1/2 ) 1. By definition t 1/2 is the time required for the concentration to fall by one half. For drugs with first order kinetics this is a constant. 2. Half-life
More informationTHE INFLUENCE OF MINERALS ON THE STABILITY OF PREMIX AND FEED COMPONENTS
THE INFLUENCE OF MINERALS ON THE STABILITY OF PREMIX AND FEED COMPONENTS Richard Murphy Ph.D. Alltech European Bioscience Centre Ireland THE INFLUENCE OF MINERALS ON THE STABILITY OF PREMIX AND FEED COMPONENTS
More informationMetabolic Changes of Drugs and Related Organic Compounds. Oxidative Reactions. Shokhan J. Hamid. 3 rd stage/ 1 st course Lecture 6
Metabolic Changes of Drugs and Related Organic Compounds Oxidative Reactions 3 rd stage/ 1 st course Lecture 6 Shokhan J. Hamid B. OXIDATION INVOLVING CARBON OXYGEN SYSTEMS: Oxidative O-dealkylation of
More informationEDUCATIONAL COMMENTARY VANCOMYCIN MONITORING
EDUCATIONAL COMMENTARY VANCOMYCIN MONITORING Commentary provided by: Julie Hall, MHS, MT (ASCP) Assistant Dean, College of Health Professions Assistant Professor, Medical Laboratory Science Grand Valley
More informationChapter 3: Biochemistry Adapted from PPT by S. Edwards. By PresenterMedia.com
Chapter 3: Biochemistry Adapted from PPT by S. Edwards By PresenterMedia.com CARBON COMPOUNDS CHAPTER 3 SECTION 1 By PresenterMedia.com Compounds LOOK NO Carbon!!! ORGANIC COMPOUNDS Compounds that contain
More informationTable of Contents. Why I Believe in Nitric Oxide Therapy. What is Nitric Oxide. Two Primary Pathways. The Importance of L-Citrulline
Our Synergy Family 2016 Table of Contents Why I Believe in Nitric Oxide Therapy 1 What is Nitric Oxide 2 Two Primary Pathways 5 The Importance of L-Citrulline 7 Other Key Ingredients 9 How Nitric Oxide
More informationNontraditional PharmD Program PRDO 7700 Pharmacokinetics Review Self-Assessment
Nontraditional PharmD Program PRDO 7700 Pharmacokinetics Review Self-Assessment Please consider the following questions. If you do not feel confident about the material being covered, then it is recommended
More informationDRUG ELIMINATION II BILIARY EXCRETION MAMMARY, SALIVARY AND PULMONARY EXCRETION
DRUG ELIMINATION II BILIARY EXCRETION MAMMARY, SALIVARY AND PULMONARY EXCRETION ROUTE OF DRUG ADMINISTRATION AND EXTRAHEPATIC DRUG METABOLISM The decline in plasma concentration after drug administration
More informationSUMMARY OF PRODUCT CHARACTERISTICS
MUTUAL RECOGNITION PROCEDURE Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT, syrup 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of syrup contains 1 mg loratadine.
More informationLoudon Chapter 21 Review: Carboxylic Acid Derivatives Jacquie Richardson, CU Boulder Last updated 3/20/2018
Loudon Chapter 21 eview: Carboxylic Acid Derivatives Jacquie ichardson, CU Boulder Last updated 3/20/2018 We learned how to make a lot of carboxylic acid derivatives from acids in Ch. 20, but now we ll
More informationPlavix duration of effect
Plavix duration of effect The Borg System is 100 % Plavix duration of effect Jan 20, 2015. If you have had stent placement after balloon angioplasty for coronary artery disease you will be placed on medications
More informationMetabolism. Objectives. Metabolism. 26 July Chapter 28 1
Metabolism bjectives Describe various processes by which drugs are metabolized Describe induction and inhibition of metabolism Use the venous equilibration model to describe hepatic clearance and the effect
More information1/3/2011. Chapter 17 Carboxylic Acids and Their Derivatives. Nucleophilic Addition- Elimination at the Acyl Carbon
Introduction The carboxyl group (-CO 2 H) is the parent group of a family of compounds called acyl compounds or carboxylic acid derivatives Chapter 17 Carboxylic Acids and Their Derivatives. Nucleophilic
More informationSTUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS
More information2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Paracetamol 80mg Suppositories 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each suppository contains 80mg Paracetamol For a full list of
More information13. Carboxylic Acids (text )
2009, Department of Chemistry, The University of Western ntario 13.1 13. Carboxylic Acids (text 14.1 14.9) A. Structure and Nomenclature The carboxylic acid functional group results from the connection
More informationBASIC PHARMACOKINETICS
BASIC PHARMACOKINETICS MOHSEN A. HEDAYA CRC Press Taylor & Francis Croup Boca Raton London New York CRC Press is an imprint of the Taylor & Francis Group, an informa business Table of Contents Chapter
More informationPHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.
PHA 5127 Second Exam Fall 2013 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question/Points Set I 20 pts Set II 20 pts Set III 20 pts Set IV 20 pts Set
More informationC OBJECTIVES. Basic Pharmacokinetics LESSON. After completing Lesson 2, you should be able to:
LESSON 2 Basic Pharmacokinetics C OBJECTIVES After completing Lesson 2, you should be able to: 1. Define the concept of apparent volume of distribution and use an appropriate mathematical equation to calculate
More informationWhen choosing an antiepileptic ... PRESENTATION... Pharmacokinetics of the New Antiepileptic Drugs. Based on a presentation by Barry E.
... PRESENTATION... Pharmacokinetics of the New Antiepileptic Drugs Based on a presentation by Barry E. Gidal, PharmD Presentation Summary A physician s choice of an antiepileptic drug (AED) usually depends
More informationDefine the terms biopharmaceutics and bioavailability.
Pharmaceutics Reading Notes Define the terms biopharmaceutics and bioavailability. Biopharmaceutics: the area of study concerning the relationship between the physical, chemical, and biological sciences
More informationPHA Final Exam Fall 2006
PHA 5127 Final Exam Fall 2006 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Please transfer the answers onto the bubble sheet. The question number refers
More informationChem 499. Spring, 2016 Beauchamp. Credit
hem 499 inal Exam pring, 2016 eauchamp ame: 1 Topic Total Points Exam Points Problem 1 6 Problem 2 6 Problem 3 5 Problem 4 5 Problem 5 14 Problem 6 14 Problem 7 5 Problem 8 13 Problem 9 9. Problem 10 8.
More informationMetabolic Changes of Drugs and Related Organic Compounds
Metabolic Changes of Drugs and Related Organic Compounds 3 rd stage/ 1 st course Lecture 3 Shokhan J. Hamid 2 Metabolism plays a central role in the elimination of drugs and other foreign compounds from
More informationBIOCHEMISTRY NOTES PT. 3 FOUR MAIN TYPES OF ORGANIC MOLECULES THAT MAKE UP LIVING THINGS
BIOCHEMISTRY NOTES PT. 3 FOUR MAIN TYPES OF ORGANIC MOLECULES THAT MAKE UP LIVING THINGS 1. 2. 3. 4. CARBOHYDRATES LIPIDS (fats) PROTEINS NUCLEIC ACIDS We call these four main types of carbon- based molecules
More informationHelping the liver to detoxify mycotoxins
Helping the liver to detoxify mycotoxins Mycotoxin strategies have so far focused on binding compounds or detoxifying the compounds by feed additives. Animals however, can also detoxify mycotoxins themselves
More informationO H 2 N. α H. Chapter 4 - Amino Acids
hapter 4 - Amino Acids Introduction Several amino acids were produced in the electrical discharge in the reducing, primordial atmosphere that gave rise to the first biomolecules (see chapter 1). The importance
More informationDMPK. APRIL 27 TH 2017 Jan Neelissen Scientific Adviser Science & Technology
DMPK APRIL 27 TH 2017 Jan Neelissen Scientific Adviser Science & Technology What I learned is a good DMPK profile have acceptable water solubility for development be completely absorbed, preferably via
More informationPHA Final Exam Fall 2001
PHA 5127 Final Exam Fall 2001 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question/Points 1. /12 pts 2. /8 pts 3. /12 pts 4. /20 pts 5. /27 pts 6. /15
More informationClinical Pharmacology. Pharmacodynamics the next step. Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland, New Zealand
1 Pharmacodynamic Principles and the Course of Immediate Drug s Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland, New Zealand The time course of drug action combines the principles
More information